travoprost intraocular implant (Pending FDA approval)

Action and Spectrum

Actions and Spectrum: 

Actions: 

This drug, a synthetic prostaglandin F analogue, is prescribed to treat ocular hypertension or open angle glaucoma. 

Spectrum: 

N/A 

Drug Interaction

Adverse Reaction

N/A 

Black Box Warning

Black Box Warning: 

N/A

Contraindication / Caution

N/A 

Pregnancy / Lactation

Pregnancy consideration:  

No data is available regarding the administration of the drug during pregnancy. 

Breastfeeding warnings:  

No data is available regarding the excretion of drug in breast milk. 

Pregnancy category: 

Category A: well-controlled and satisfactory studies show no risk to the fetus in the first or later trimester. 

Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. 

Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.    

Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.    

Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.    

Category N: No data is available for the drug under this category. 

Pharmacology

Pharmacology: 

Prostaglandin F2-alpha analog: increases aqueous humor outflow through the trabecular meshwork, lowering intraocular pressure. Pharmacodynamics: N/A 

Pharmacokinetics: N/A 

Adminstartion

Administration: 

Pending FDA approval 

Patient Information Leaflet

Patient information leaflet 

Generic Name: travoprost intraocular implant 

Pronounced: trah-VOH-prost in-truh-AHK-yuh-ler im-plant 

Why do we use travoprost intraocular implant? 

This drug, a synthetic prostaglandin F analogue, is prescribed to treat ocular hypertension or open angle glaucoma. By encouraging the eye’s natural fluids to flow out more readily, it reduces intraocular pressure.